High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.3M
$1,294,179
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -30.1%
2026-03-20
$292,359
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -30.1%
|
2026-03-20 | $292,359 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 Sell
2026-03-20
$20,679
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 Sell
|
2026-03-20 | $20,679 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-18
$2,365
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-18 | $2,365 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-18
$10,617
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-18 | $10,617 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to CoverΔOwn -12.6%
2026-03-18
$132,080
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to CoverΔOwn -12.6%
|
2026-03-18 | $132,080 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-17
$81,063
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-17 | $81,063 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-17
$59,775
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-17 | $59,775 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -12.9%
2025-12-05
$74,445
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -12.9%
|
2025-12-05 | $74,445 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-05
$31,456
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-05 | $31,456 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -23.1%
2025-12-05
$168,997
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -23.1%
|
2025-12-05 | $168,997 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$6,075
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $6,075 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$25,349
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $25,349 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$27,244
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $27,244 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$43,002
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $43,002 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$41,860
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $41,860 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$26,163
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $26,163 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Other
2025-10-03
$91,500
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Other
|
2025-10-03 | $91,500 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
2025-10-03
$250,650
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
|
2025-10-03 | $250,650 | S | Form 4 |